Choroidal neovascularisation
An abnormal growth of blood vessels in the choroid layer of the eye
Choroidal neovascularisation (CNV) is a pathological condition characterized by the growth of new blood vessels originating from the choroid, a vascular layer of the eye, into the retina. This process is often associated with severe vision loss and is a hallmark of several ocular diseases, most notably age-related macular degeneration (AMD).
Pathophysiology[edit | edit source]
The choroid is a layer of blood vessels and connective tissue between the sclera and the retina. In CNV, new blood vessels break through the Bruch's membrane and invade the subretinal space. These vessels are often fragile and prone to leakage, leading to subretinal hemorrhage and fluid accumulation. This can result in retinal detachment and scarring, ultimately causing vision impairment.
Causes[edit | edit source]
CNV is most commonly associated with:
- Age-related macular degeneration (AMD)
- Pathologic myopia
- Ocular histoplasmosis syndrome
- Angioid streaks
- Choroidal rupture
Symptoms[edit | edit source]
Patients with CNV may experience:
- Distorted vision (metamorphopsia)
- Reduced central vision
- Dark or empty areas in the central vision (scotomas)
- Sudden onset of visual changes
Diagnosis[edit | edit source]
Diagnosis of CNV typically involves:
- Optical coherence tomography (OCT) to visualize the retina and choroid
- Fluorescein angiography to assess blood flow and identify leaking vessels
- Indocyanine green angiography for deeper choroidal imaging
Treatment[edit | edit source]
Treatment options for CNV include:
- Anti-VEGF therapy: Intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents such as ranibizumab, bevacizumab, and aflibercept
- Photodynamic therapy (PDT) with verteporfin
- Laser photocoagulation for certain types of CNV
Prognosis[edit | edit source]
The prognosis for CNV varies depending on the underlying cause and the timeliness of treatment. Early detection and treatment with anti-VEGF agents have significantly improved outcomes, reducing the risk of severe vision loss.
Also see[edit | edit source]
- Age-related macular degeneration
- Retinal detachment
- Optical coherence tomography
- Fluorescein angiography
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD